Filter by: Subject

Please be advised that the site will be down for maintenance on Sunday, September 1, 2024, from 08:00 to 18:00, and again on Monday, September 2, 2024, from 08:00 to 09:00. We apologize for any inconvenience this may cause.

Filter by: Subject

Results Per Page:

Antiretroviral therapy (ART) (21)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (20)
Health sciences article SDG-03 (17)
Treatment (17)
Streptococcus pneumoniae (15)
Mesenchymal stromal/stem cells (MSCs) (14)
Patients (14)
Tuberculosis (TB) (14)
Platelets (13)
Pneumococcus (13)
Neutrophils (12)
Community-acquired pneumonia (CAP) (11)
Inflammation (10)
Mortality (10)
Biomarkers (9)
Children (9)
Pneumolysin (9)
Cancer (8)
Cytokines (8)
HIV-1 (8)
Infection (8)
Reactive oxygen species (8)
Gene therapy (7)
Immunotherapy (7)
Macrolides (7)
South Africa (7)
Africa (6)
Breast cancer (6)
Immunosuppression (6)
Lung cancer (6)
Mycobacterium tuberculosis (MTB) (6)
Vaccine (6)
Angiogenesis (5)
Chemotherapy (5)
Corticosteroids (5)
Disease (5)
Drug resistance (5)
Ethics (5)
Human leukocyte antigen (HLA) (5)
Immune activation (5)
Immune dysregulation (5)
In vitro (5)
In vivo (5)
Low- and middle-income countries (LMICs) (5)
Luteinizing hormone (LH) (5)
Obesity (5)
People living with HIV (PLWHIV) (5)
Rheumatoid arthritis (RA) (5)
Smoking (5)
Acquired immune deficiency syndrome (AIDS) (4)
Adipose tissue (4)
Antibiotics (4)
Calcium (4)
Cell therapy (4)
Community-acquired pneumonia (4)
Diagnosis (4)
Febrile neutropenia (4)
Growth (4)
Hydrogen peroxide (4)
Immune checkpoint inhibitor (ICI) (4)
Immune checkpoint inhibitors (4)
Immune system (4)
Informed consent (4)
Kisspeptin (4)
Macrophages (4)
Microbial translocation (4)
Nausea (4)
Nivolumab (4)
Oxytocin (4)
Pharmacogenetics (4)
Pneumonia (4)
Stem cells (4)
Toll-like receptors (4)
Vaccines (4)
Vasopressin (4)
Adipogenesis (3)
Antibiotic resistance (3)
Antiretroviral agents -- South Africa (3)
Antiretroviral treatment (ART) (3)
Autoantibodies (3)